Lifecore Biomedical Stock Last Dividend Paid

LFCR Stock

6.55 0.03 0.46%

Lifecore Biomedical fundamentals help investors to digest information that contributes to Lifecore Biomedical's financial success or failures. It also enables traders to predict the movement of Lifecore Stock. The fundamental analysis module provides a way to measure Lifecore Biomedical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Lifecore Biomedical stock.

Short Long Term Debt Total Total Assets

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Lifecore Biomedical Company Last Dividend Paid Analysis

Lifecore Biomedical's Last Dividend Paid refers to dividend per share(DPS) paid to the shareholder the last time dividends were issued by a company. In its conventional sense, dividends refer to the distribution of some of a company's net earnings or capital gains decided by the board of directors.

Last Dividend

Last Profit Distribution Amount

Total Shares

More About Last Dividend Paid | All Equity Analysis

Lifecore Last Dividend Paid Driver Correlations

Understanding the fundamental principles of building solid financial models for Lifecore Biomedical is extremely important. It helps to project a fair market value of Lifecore Stock properly, considering its historical fundamentals such as Last Dividend Paid. Since Lifecore Biomedical's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Lifecore Biomedical's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Lifecore Biomedical's interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Total Liab	Total Current Assets	Short Term Debt	Net Receivables	Intangible Assets	Common Stock	Current Deferred Revenue	Short Term Investments	Good Will	Net Tangible Assets	Long Term Debt	Net Invested Capital	Long Term Investments	Short Long Term Debt	Capital Stock	Net Working Capital	Property Plant Equipment
Total Assets		0.76	0.62	0.48	0.75	0.69	0.85	0.4	0.89	0.31	-0.66	-0.48	-0.66	0.69	0.24	0.21	0.25	0.04	0.26	-0.2	-0.08	0.15
Total Stockholder Equity	0.76		0.0	0.91	0.8	0.08	0.45	0.17	0.77	0.63	-0.42	-0.46	-0.64	0.89	0.72	-0.34	0.71	0.63	0.69	-0.61	-0.6	0.66
Net Debt	0.62	0.0		-0.28	0.16	0.94	0.84	0.56	0.46	-0.31	-0.41	-0.21	-0.24	0.02	-0.44	0.67	-0.41	-0.67	-0.38	0.31	0.6	-0.53
Retained Earnings	0.48	0.91	-0.28		0.6	-0.27	0.22	0.11	0.52	0.72	-0.09	-0.38	-0.46	0.87	0.9	-0.55	0.87	0.83	0.86	-0.82	-0.75	0.83
Accounts Payable	0.75	0.8	0.16	0.6		0.32	0.48	0.2	0.89	0.53	-0.5	-0.46	-0.54	0.71	0.4	-0.33	0.48	0.48	0.57	-0.28	-0.56	0.58
Total Liab	0.69	0.08	0.94	-0.27	0.32		0.78	0.38	0.53	-0.22	-0.57	-0.25	-0.3	0.09	-0.43	0.69	-0.37	-0.62	-0.37	0.4	0.49	-0.48
Total Current Assets	0.85	0.45	0.84	0.22	0.48	0.78		0.69	0.76	0.16	-0.56	-0.47	-0.56	0.39	-0.02	0.35	-0.05	-0.29	0.03	-0.08	0.28	-0.15
Short Term Debt	0.4	0.17	0.56	0.11	0.2	0.38	0.69		0.44	-0.03	-0.2	-0.33	-0.31	0.05	-0.21	-0.03	-0.26	-0.19	-0.05	-0.13	0.29	-0.09
Net Receivables	0.89	0.77	0.46	0.52	0.89	0.53	0.76	0.44		0.34	-0.66	-0.53	-0.69	0.6	0.25	-0.14	0.27	0.19	0.41	-0.22	-0.25	0.32
Intangible Assets	0.31	0.63	-0.31	0.72	0.53	-0.22	0.16	-0.03	0.34		-0.19	-0.48	-0.43	0.68	0.71	-0.39	0.69	0.65	0.66	-0.59	-0.61	0.65
Common Stock	-0.66	-0.42	-0.41	-0.09	-0.5	-0.57	-0.56	-0.2	-0.66	-0.19		0.5	0.83	-0.16	0.17	-0.17	0.17	0.21	0.16	-0.13	-0.19	0.18
Current Deferred Revenue	-0.48	-0.46	-0.21	-0.38	-0.46	-0.25	-0.47	-0.33	-0.53	-0.48	0.5		0.57	-0.41	-0.24	0.18	-0.25	-0.19	-0.31	0.26	0.18	-0.25
Short Term Investments	-0.66	-0.64	-0.24	-0.46	-0.54	-0.3	-0.56	-0.31	-0.69	-0.43	0.83	0.57		-0.39	-0.18	0.13	-0.14	-0.13	-0.18	0.42	0.06	-0.14
Good Will	0.69	0.89	0.02	0.87	0.71	0.09	0.39	0.05	0.6	0.68	-0.16	-0.41	-0.39		0.81	-0.19	0.83	0.66	0.75	-0.63	-0.66	0.71
Net Tangible Assets	0.24	0.72	-0.44	0.9	0.4	-0.43	-0.02	-0.21	0.25	0.71	0.17	-0.24	-0.18	0.81		-0.49	0.97	0.85	0.91	-0.77	-0.81	0.84
Long Term Debt	0.21	-0.34	0.67	-0.55	-0.33	0.69	0.35	-0.03	-0.14	-0.39	-0.17	0.18	0.13	-0.19	-0.49		-0.47	-0.8	-0.65	0.53	0.73	-0.76
Net Invested Capital	0.25	0.71	-0.41	0.87	0.48	-0.37	-0.05	-0.26	0.27	0.69	0.17	-0.25	-0.14	0.83	0.97	-0.47		0.87	0.91	-0.72	-0.88	0.87
Long Term Investments	0.04	0.63	-0.67	0.83	0.48	-0.62	-0.29	-0.19	0.19	0.65	0.21	-0.19	-0.13	0.66	0.85	-0.8	0.87		0.88	-0.72	-0.96	0.97
Short Long Term Debt	0.26	0.69	-0.38	0.86	0.57	-0.37	0.03	-0.05	0.41	0.66	0.16	-0.31	-0.18	0.75	0.91	-0.65	0.91	0.88		-0.72	-0.9	0.94
Capital Stock	-0.2	-0.61	0.31	-0.82	-0.28	0.4	-0.08	-0.13	-0.22	-0.59	-0.13	0.26	0.42	-0.63	-0.77	0.53	-0.72	-0.72	-0.72		0.59	-0.71
Net Working Capital	-0.08	-0.6	0.6	-0.75	-0.56	0.49	0.28	0.29	-0.25	-0.61	-0.19	0.18	0.06	-0.66	-0.81	0.73	-0.88	-0.96	-0.9	0.59		-0.97
Property Plant Equipment	0.15	0.66	-0.53	0.83	0.58	-0.48	-0.15	-0.09	0.32	0.65	0.18	-0.25	-0.14	0.71	0.84	-0.76	0.87	0.97	0.94	-0.71	-0.97

Click cells to compare fundamentals

Many stable companies today pay out dividends to their shareholders in the form of the income distribution, but high-growth firms rarely offer dividends because all of their earnings are reinvested back to the business.

Competition

Predict Lifecore Biomedical

Lifecore Dividends Paid

Dividends Paid

2.63 Million

At this time, Lifecore Biomedical's Dividends Paid is relatively stable compared to the past year.

Based on the recorded statements, Lifecore Biomedical has a Last Dividend Paid of 0.0. This indicator is about the same for the Biotechnology average (which is currently at 0.0) sector and about the same as Health Care (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).

Did you try this?

Run Volatility Analysis Now

Volatility Analysis

Get historical volatility and risk analysis based on latest market data

All Next

Launch Module

Lifecore Biomedical ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Lifecore Biomedical's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Lifecore Biomedical's managers, analysts, and investors.

Environmental

Governance

Social

Lifecore Fundamentals

	Return On Equity	-0.3
	Return On Asset	-0.0247
	Profit Margin	(0.11) %
	Operating Margin	(0.05) %
	Current Valuation	364.22 M
	Shares Outstanding	37.03 M
	Shares Owned By Insiders	4.52 %
	Shares Owned By Institutions	73.59 %
	Number Of Shares Shorted	2.4 M
	Price To Book	15.69 X
	Price To Sales	1.85 X
	Revenue	128.26 M
	Gross Profit	45.64 M
	EBITDA	35.6 M
	Net Income	9.33 M
	Total Debt	130.36 M
	Book Value Per Share	0.42 X
	Cash Flow From Operations	(217 K)
	Short Ratio	19.93 X
	Earnings Per Share	(0.56) X
	Price To Earnings To Growth	3.51 X
	Target Price	10.0
	Number Of Employees	524
	Beta	0.97
	Market Capitalization	242.52 M
	Total Asset	273.7 M
	Retained Earnings	(166.52 M)
	Working Capital	42.16 M
	Net Asset	273.7 M

About Lifecore Biomedical Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Lifecore Biomedical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Lifecore Biomedical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Lifecore Biomedical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Additional Tools for Lifecore Stock Analysis

When running Lifecore Biomedical's price analysis, check to measure Lifecore Biomedical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lifecore Biomedical is operating at the current time. Most of Lifecore Biomedical's value examination focuses on studying past and present price action to predict the probability of Lifecore Biomedical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lifecore Biomedical's price. Additionally, you may evaluate how the addition of Lifecore Biomedical to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC